Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) EBIT (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of EBIT data on record, last reported at $4.1 million in Q4 2025.

  • For Q4 2025, EBIT fell 7.37% year-over-year to $4.1 million; the TTM value through Oct 2025 reached $19.7 million, up 20.12%, while the annual FY2025 figure was $17.8 million, 2.86% down from the prior year.
  • EBIT reached $4.1 million in Q4 2025 per KEQU's latest filing, down from $4.8 million in the prior quarter.
  • Across five years, EBIT topped out at $8.5 million in Q2 2025 and bottomed at -$2.9 million in Q4 2021.
  • Average EBIT over 5 years is $2.3 million, with a median of $2.4 million recorded in 2023.
  • Peak YoY movement for EBIT: plummeted 26172.73% in 2021, then soared 1061.62% in 2023.
  • A 5-year view of EBIT shows it stood at -$2.9 million in 2021, then surged by 126.12% to $755000.0 in 2022, then soared by 576.69% to $5.1 million in 2023, then dropped by 13.21% to $4.4 million in 2024, then dropped by 7.37% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $4.1 million in Q4 2025, $4.8 million in Q3 2025, and $8.5 million in Q2 2025.